Intellectual Property
Seurat Therapeutics exclusively licensed from the University of Chicago, a diverse portfolio of issued and pending US and international patents and patent applications for methods of use of IGF-1 for treatment of various neurological disorders and syndromes, including migraine headaches, migraine aura, fibromyalgia, other chronic pain syndromes, and seizure disorders.
Issued US Patents
| Patent No. | Title |
| 10,391,150 | Treatments for migraine and related disorders |
| 9,827,294 | Treatments for migraine and related disorders |
| 9,399,053 | Treatments for migraine and related disorders |